Dr. Wester is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
21st Ave S
# A-2200
Nashville, TN 37232Phone+1 615-322-8792
Summary
- I am board certified in Internal Medicine and Infectious Diseases and am actively engaged in HIV research; with a specific focus on scale-up of comprehensive HIV services in sub-Saharan Africa (i.e. Botswana, Nigeria, and Mozambique) with a research focus on implementation science and Non Communicable Diseases (NCDs)(with a specific focus on prevention of HIV-associated kidney complications).
Education & Training
- Harvard School of Public HealthM.P.H., Quantitative Methods , 2010
- Rush University Medical CenterFellowship, Infectious Disease, 1996 - 1998
- Rush University Medical CenterResidency, Internal Medicine, 1991 - 1995
- Geisel School of Medicine at DartmouthClass of 1991
- Bowdoin CollegeB.A., Biology and Economics , 1983 - 1987
Certifications & Licensure
- TN State Medical License 2008 - 2026
- IL State Medical License 1993 - 2002
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Clinical Trials
- Pilot Study of Bydureon to Treat Diabetes in HIV-infected Adults Start of enrollment: 2013 Mar 01
- Optimal Management of HIV Infected Adults at Risk for Kidney Complications in Nigeria Start of enrollment: 2024 Jul 01
Publications & Presentations
PubMed
- 15 citationsApolipoprotein-1 risk variants and associated kidney phenotypes in an adult HIV cohort in NigeriaUsman J. Wudil, Muktar H. Aliyu, Heather L. Prigmore, Donna J. Ingles, Aima A. Ahonkhai
Kidney International. 2021-07-01 - 11 citationsOptimal management of HIV- positive adults at risk for kidney disease in Nigeria (Renal Risk Reduction "R3" Trial): protocol and study design.Muktar H. Aliyu, Usman J. Wudil, Donna J. Ingles, Bryan E. Shepherd, Wu Gong
Trials. 2019-06-10 - 212 citationsRising Obesity Prevalence and Weight Gain Among Adults Starting Antiretroviral Therapy in the United States and Canada.John R. Koethe, Cathy A. Jenkins, Bryan Lau, Bryan E. Shepherd, Amy C. Justice
AIDS Research and Human Retroviruses. 2016-01-01
Journal Articles
- The Impact of Statin and Angiotensin-Converting Enzyme Inhibitor/Angiotensin Receptor Blocker Therapy on Cognitive Function in Adults with Human Immunodeficiency Virus...C William Wester, Edgar Turner Overton, Susan L Koletar, Kristine M Erlandson, Constance A Benson, Robert C Kalayjian, Clinical Infectious Diseases
Grant Support
- Optimal Management of HIV Infected Adults at Risk for Kidney Disease in NigeriaNIDDK2017–2022
- Avante: Towards Epidemic Control (Mozambique)CDC/PEPFAR2016–2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: